SI3097084T1 - Novi zaviralci kalikreina 7 - Google Patents
Novi zaviralci kalikreina 7Info
- Publication number
- SI3097084T1 SI3097084T1 SI201531440T SI201531440T SI3097084T1 SI 3097084 T1 SI3097084 T1 SI 3097084T1 SI 201531440 T SI201531440 T SI 201531440T SI 201531440 T SI201531440 T SI 201531440T SI 3097084 T1 SI3097084 T1 SI 3097084T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inhibitors
- kallikrein
- new
- new kallikrein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1430004 | 2014-01-23 | ||
| EP15740983.0A EP3097084B1 (en) | 2014-01-23 | 2015-01-22 | New kallikrein 7 inhibitors |
| PCT/SE2015/050060 WO2015112079A1 (en) | 2014-01-23 | 2015-01-22 | New kallikrein 7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3097084T1 true SI3097084T1 (sl) | 2021-01-29 |
Family
ID=53681745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201531440T SI3097084T1 (sl) | 2014-01-23 | 2015-01-22 | Novi zaviralci kalikreina 7 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9744148B2 (sl) |
| EP (1) | EP3097084B1 (sl) |
| JP (2) | JP6552010B2 (sl) |
| CN (1) | CN106132940B (sl) |
| AU (1) | AU2015209759B2 (sl) |
| CA (1) | CA2934024C (sl) |
| CY (1) | CY1123707T1 (sl) |
| DK (1) | DK3097084T3 (sl) |
| ES (1) | ES2834851T3 (sl) |
| HR (1) | HRP20201915T1 (sl) |
| HU (1) | HUE052990T2 (sl) |
| LT (1) | LT3097084T (sl) |
| PT (1) | PT3097084T (sl) |
| RS (1) | RS61142B1 (sl) |
| SI (1) | SI3097084T1 (sl) |
| WO (1) | WO2015112079A1 (sl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS61142B1 (sr) * | 2014-01-23 | 2020-12-31 | Sixera Pharma Ab | Novi inhibitori kalikreina 7 |
| EP3305781A1 (en) * | 2016-10-07 | 2018-04-11 | Deutsches Krebsforschungszentrum | Chemical substances which inhibit the enzymatic activity of human kallikrein-related peptidase 6 (klk6) |
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| GB201809378D0 (en) | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2514355A1 (fr) * | 1981-10-14 | 1983-04-15 | Fabre Sa Pierre | Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments |
| AU2003231865A1 (en) | 2002-05-31 | 2003-12-19 | Genzyme Corporation | Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| CA2525383C (en) | 2003-06-06 | 2012-03-06 | Arexis Ab | Use of heterocyclic compounds as scce inhibitors |
| CA2670458C (en) * | 2006-11-23 | 2016-01-05 | Vib Vzw | Activators of lateral root formation |
| KR20100027159A (ko) | 2007-06-28 | 2010-03-10 | 노파르티스 아게 | 칼리크레인 7 조절제 |
| AU2008290567B2 (en) | 2007-08-17 | 2011-05-12 | Novartis Ag | Cyclic depsipeptides |
| JP5401459B2 (ja) * | 2007-08-17 | 2014-01-29 | ノバルティス アーゲー | カリクレイン７を阻害するための環状デプシペプチドの使用 |
| US8143269B2 (en) * | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| EP2545916A1 (en) | 2011-07-15 | 2013-01-16 | Universite Pierre Et Marie Curie - Paris 6 | Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
| RS61142B1 (sr) * | 2014-01-23 | 2020-12-31 | Sixera Pharma Ab | Novi inhibitori kalikreina 7 |
-
2015
- 2015-01-22 RS RS20201461A patent/RS61142B1/sr unknown
- 2015-01-22 CA CA2934024A patent/CA2934024C/en active Active
- 2015-01-22 DK DK15740983.0T patent/DK3097084T3/da active
- 2015-01-22 SI SI201531440T patent/SI3097084T1/sl unknown
- 2015-01-22 WO PCT/SE2015/050060 patent/WO2015112079A1/en active Application Filing
- 2015-01-22 EP EP15740983.0A patent/EP3097084B1/en active Active
- 2015-01-22 AU AU2015209759A patent/AU2015209759B2/en not_active Ceased
- 2015-01-22 JP JP2016544671A patent/JP6552010B2/ja active Active
- 2015-01-22 HU HUE15740983A patent/HUE052990T2/hu unknown
- 2015-01-22 US US15/113,658 patent/US9744148B2/en active Active
- 2015-01-22 CN CN201580005402.3A patent/CN106132940B/zh active Active
- 2015-01-22 LT LTEP15740983.0T patent/LT3097084T/lt unknown
- 2015-01-22 ES ES15740983T patent/ES2834851T3/es active Active
- 2015-01-22 PT PT157409830T patent/PT3097084T/pt unknown
-
2019
- 2019-05-14 JP JP2019091722A patent/JP6932386B2/ja active Active
-
2020
- 2020-12-01 HR HRP20201915TT patent/HRP20201915T1/hr unknown
- 2020-12-04 CY CY20201101150T patent/CY1123707T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3097084A4 (en) | 2017-10-04 |
| PT3097084T (pt) | 2020-12-09 |
| HUE052990T2 (hu) | 2021-05-28 |
| DK3097084T3 (da) | 2020-12-21 |
| EP3097084B1 (en) | 2020-09-30 |
| CN106132940A (zh) | 2016-11-16 |
| JP2019163296A (ja) | 2019-09-26 |
| AU2015209759B2 (en) | 2018-11-29 |
| EP3097084A1 (en) | 2016-11-30 |
| AU2015209759A1 (en) | 2016-07-07 |
| WO2015112079A1 (en) | 2015-07-30 |
| CA2934024C (en) | 2022-08-23 |
| ES2834851T3 (es) | 2021-06-18 |
| JP6552010B2 (ja) | 2019-07-31 |
| CY1123707T1 (el) | 2022-03-24 |
| US20170000753A1 (en) | 2017-01-05 |
| HRP20201915T1 (hr) | 2021-01-22 |
| LT3097084T (lt) | 2020-12-28 |
| US9744148B2 (en) | 2017-08-29 |
| RS61142B1 (sr) | 2020-12-31 |
| JP6932386B2 (ja) | 2021-09-08 |
| CA2934024A1 (en) | 2015-07-30 |
| CN106132940B (zh) | 2019-04-23 |
| JP2017505299A (ja) | 2017-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287113A (en) | smyd inhibitors | |
| IL280785A (en) | Human plasma kallikrein inhibitors | |
| IL259560A (en) | Inhibitors of the menin-mll interaction | |
| IL257880B (en) | Beta-lactamase inhibitors | |
| IL250642B (en) | glycosidase inhibitors | |
| IL246362A0 (en) | Novel glutaminase inhibitors | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
| GB201421088D0 (en) | New enzyme inhibitors | |
| IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| GB201416446D0 (en) | New enzyme inhibitor compounds | |
| GB201421085D0 (en) | New enzyme inhibitors | |
| GB201403536D0 (en) | Inhibitor compounds | |
| IL265139B (en) | Dopamine-b-hydroxylase inhibitors | |
| HUE066987T2 (hu) | Szelektív il-6-transz-szignalizációt gátló szert tartalmazó készítmények | |
| GB201501004D0 (en) | Inhibitors | |
| GB201612860D0 (en) | Inhibitors | |
| RS61142B1 (sr) | Novi inhibitori kalikreina 7 | |
| DK3237407T3 (da) | 3,5-diaminopyrazolkinasehæmmere | |
| GB201520949D0 (en) | Inhibitors | |
| GB201401005D0 (en) | Inhibitor | |
| GB201418154D0 (en) | Inhibitors |